Universe Pharmaceuticals INC (UPC)
NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-market:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 8.50M |
| Enterprise value | -4.53M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 0.26 |
| Price/book (mrq) | 0.21 |
| Enterprise value/revenue | -0.06 |
| Enterprise value/EBITDA | 0.31 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.66 |
| 52-week change 3 | -42.47% |
| S&P500 52-week change 3 | 28.04% |
| 52-week high 3 | 5.8800 |
| 52-week low 3 | 0.7500 |
| 50-day moving average 3 | 2.0839 |
| 200-day moving average 3 | 1.6195 |
Share statistics
| Avg vol (3-month) 3 | 76.18k |
| Avg vol (10-day) 3 | 29.5k |
| Shares outstanding 5 | 3.65M |
| Implied shares outstanding 6 | 3.65M |
| Float 8 | 1.55M |
| % held by insiders 1 | 57.05% |
| % held by institutions 1 | 0.08% |
| Shares short (30 Apr 2024) 4 | 7.74k |
| Short ratio (30 Apr 2024) 4 | 0.07 |
| Short % of float (30 Apr 2024) 4 | 0.49% |
| Short % of shares outstanding (30 Apr 2024) 4 | 0.21% |
| Shares short (prior month 28 Mar 2024) 4 | 8.43k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:6 |
| Last split date 3 | 28 Jul 2023 |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Sept 2023 |
| Most-recent quarter (mrq) | 30 Sept 2023 |
Profitability
| Profit margin | -19.08% |
| Operating margin (ttm) | -26.56% |
Management effectiveness
| Return on assets (ttm) | -3.91% |
| Return on equity (ttm) | -14.34% |
Income statement
| Revenue (ttm) | 32.31M |
| Revenue per share (ttm) | 8.91 |
| Quarterly revenue growth (yoy) | -13.20% |
| Gross profit (ttm) | N/A |
| EBITDA | -3.02M |
| Net income avi to common (ttm) | -6.16M |
| Diluted EPS (ttm) | -1.7000 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 18.5M |
| Total cash per share (mrq) | 5.11 |
| Total debt (mrq) | 5.48M |
| Total debt/equity (mrq) | 13.87% |
| Current ratio (mrq) | 2.68 |
| Book value per share (mrq) | 10.91 |
Cash flow statement
| Operating cash flow (ttm) | 1.12M |
| Levered free cash flow (ttm) | 1.59M |
© 2024 Yahoo. All rights reserved.